Gráfico histórico
Evolución del precio en 1 año
El gráfico usa cierres diarios ajustados por el proveedor disponible. Puede haber retrasos, huecos o diferencias frente a la fuente oficial.
Fuentes
- Is Eli Lilly (LLY) Undervalued After Novo Nordisk’s GLP 1 Advertising Lawsuit? | yahoo_rss | 2026-07-21T23:14:16Z
- "Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks. | yahoo_rss | 2026-07-21T21:54:01Z
- Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads | yahoo_rss | 2026-07-21T21:25:15Z
Tesis
Eli Lilly is the subject of a newly public legal dispute with Novo Nordisk over weight-loss drug advertising (multiple news items dated 21 July). The lawsuit is an immediate fundamental/legal catalyst that can affect sentiment and create downside/upside volatility in the short term.
Catalizador
Novo Nordisk lawsuit alleging 'deceptive' advertising against Eli Lilly (reported 2026-07-21) — active legal/court process and press coverage. | 0-30d
Riesgos
- Legal outcomes are uncertain and may take months; immediate market reaction could be muted or temporary.
- Coverage is early-stage reporting of the suit; further details could materially change impact.
Invalidación
- If the suit is dismissed quickly or lacks merit, the negative sentiment catalyst would be invalidated.
Indicadores
Valores usados por el motor de scoring Python de este framework en el momento de la deteccion. Solo se muestran los que la fuente de datos pudo confirmar.
Volumen
2,090,700
Seguimiento
| Horizonte | Fecha | Precio | Retorno | Fuente |
|---|---|---|---|---|
| Actual | 2026-07-25 08:00:01.877453 | 1185.87 | 0.89% | yahoo |
| 1d | 2026-07-23 18:00:01.979223 | 1183.19 | 0.66% | yahoo |